Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Advanced non squamous cell, lung cancer
No prior treatment for lung cancer except prior adjuvant therapy if last dose was \>12 months prior to enrollment
You may not be if
Prior therapy for advanced lung cancer
The need for blood-thinners
Coughing up blood
Clareo Health | A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.
